Abstract
An infectious disease with obstructive hydronephrosis, pyonephrosis causes suppurative destruction of the renal parenchyma. In such cases, retrograde ureteric stenting is considered a good choice for the drainage of pyonephrosis, as an alternative to percutaneous nephrostomy and nephrectomy. The complication rate is minimal in retrograde ureteric stenting compared with about 4% in percutaneous nephrostomy.
Keywords: double‐J catheter, hydronephrosis, pyonephrosis, ureteric stent
An infectious disease with obstructive hydronephrosis, pyonephrosis causes suppurative destruction of the renal parenchyma. In such cases, retrograde ureteric stenting is considered a good choice for the drainage of pyonephrosis, as an alternative to percutaneous nephrostomy and nephrectomy. The complication rate is minimal in retrograde ureteric stenting compared with about 4% in percutaneous nephrostomy.
1. CASE SUMMARY
A 74‐year‐old woman presented to the emergent department with high fever and bilateral flank pain. Her medical history showed up cervical cancer, for which she had had radical hysterectomy, lymphadenectomy, and salpingo‐oophorectomy. Clinicians then performed regular double‐J catheter revision on the patient due to bilateral ureteral stricture.
A subsequent examination went on to reveal tenderness on tapping the costovertebral angle. Urinalysis revealed pyuria, leukocytosis (white‐cell count of 16 650 mm3), elevated C‐reactive protein levels (212.2 mg/L), hyperkalemia (5.2 mmol/L), and deteriorated renal function (eGFR:12.61 mL/min/1.73 m2). Computational tomography of the abdomen showed persistent bilateral hydronephrosis (Figure 1). Cystoscopy revealed turbid urine because the right double‐J catheter, placed 3 months previously, had been dislodged. On this basis, bilateral double‐J stenting was performed to revise the last. Following this, pus‐like material drained from a side hole of the double‐J stent, confirming the diagnosis of pyonephrosis (Figure 2, Video S1). Continuous bladder irrigation was done, along with the drainage of the double‐J catheter. The patient's condition gradually improved, until she was discharged.
Pyonephrosis is an infectious disease usually accompanied by obstructive hydronephrosis, which causes the suppurative destruction of the renal parenchyma. Retrograde ureteric stenting is a good choice for the drainage of pyonephrosis, as an alternative to percutaneous nephrostomy and nephrectomy. 1 Both retrograde ureteric stenting and percutaneous nephrostomy are comparably effective in the decompression and resolution of sepsis. The complication rate of retrograde ureteric stenting is minimal, but for percutaneous nephrostomy, it is about 4%. 2
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
AUTHOR CONTRIBUTIONS
CNH: performed the surgery. CWC: reviewed this case and was a major contributor in writing the manuscript. All authors read and approved the final manuscript.
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
Approval for the study was obtained from the institutional review board of Kaohsiung Municipal Ta‐Tung Hospital.
CONSENT FOR PUBLICATION
Informed consent was obtained from the patient for the publication of this case report.
Supporting information
Chang C‐W, Huang C‐N. Pyonephrosis drained by double‐J catheter. Clin Case Rep. 2020;8:3586–3587. 10.1002/ccr3.3204
DATA AVAILABILITY STATEMENT
The authors do not wish to share the patient's data. The privacy of this participant should be protected.
REFERENCE
- 1. Flukes S, Hayne D, Kuan M, Wallace M, McMillan K, Rukin NJ. Retrograde ureteric stent insertion in the management of infected obstructed kidneys. BJU Int. 2015;115(Suppl 5):31‐34. [DOI] [PubMed] [Google Scholar]
- 2. Ramsey S, Robertson A, Ablett MJ, Meddings RN, Hollins GW, Little B. Evidence‐based drainage of infected hydronephrosis secondary to ureteric calculi. J Endourol. 2010;24(2):185‐189. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The authors do not wish to share the patient's data. The privacy of this participant should be protected.